Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia

American Journal of Cardiology

Volumn 102, Issue 9, 2008, Pages 1199-1204

  Hudgins, Lisa C ^a,b   Kleinman, Bryan ^a   Scheuer, Abby ^a,b   White, Sharon ^b   Gordon, Bruce R ^a,b  

^a ROGOSIN INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANGIOGRAPHY; APHERESIS; ARTICLE; BACTEREMIA; CHILD; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; ECHOCARDIOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEADACHE; HOMOZYGOSITY; HUMAN; HYPOTENSION; LONG TERM CARE; MALE; NAUSEA; PRIORITY JOURNAL; RISK ASSESSMENT; THORAX PAIN; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; MALE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 54549104832     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.049     Document Type: Article

References (12)

1. Gordon B.R., and Hudgins L.C. The steps beyond diet and drug therapy for severe hypercholesterolemia. In: Antman E.M. (Ed). Cardiovascular Therapeutics (2007), Elsevier, New York 589-600
2. Hudgins L.C., Gordon B.R., Parker T.S., Saal S.D., Levine D.M., and Rubin A.L. LDL apheresis: an effective and safe treatment for refractory hypercholesterolemia. Cardiovasc Drug Rev 20 (2002) 271-280
3. Stefanutti C., Lanti A., Di Giacomo S., Mareri M., De Lorenzo F., Landolfo A., and Isacchi G. Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks. Transfus Apher Sci 31 (2004) 3-10
4. Stefanutti C., Di Giacomo S., Vivenzio A., Colloridi V., Bosco G., Berni A., Rabbone I., Cerutti F., and Bertolini S. Low-density lipoprotein apheresis in a patient aged 3.5 years. Acta Paediatr 90 (2001) 694-701
5. Kroon A.A., Aengevaeren W.R., van der Werf T., Uijen G.J., Reiber J.H., Bruschke A.V., and Stalenhoef A.F. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 93 (1996) 1826-1835
6. Starzl T.E., Chase H.P., Ahrens Jr. E.H., McNamara D.J., Bilheimer D.W., Schaefer E.J., Rey J., Porter K.A., Stein E., Francavilla A., and Benson L.N. Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg 198 (1983) 273-283
7. Gordon B.R., Kelsey S.F., Dau P.C., Gotto Jr. A.M., Graham K., Illingworth D.R., Isaacsohn J., Jones P.H., Leitman S.F., Saal S.D., et al. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. Am J Cardiol 81 (1998) 407-411
8. Keller C., Grutzmacher P., Bahr F., Schwarzbeck A., Kroon A.A., and Kiral A. LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors. Lancet 341 (1993) 60-61
9. Makino H., and Harada-Shiba M. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Ther Apher Dial 7 (2003) 397-401
10. Zwiener R.J., Uauy R., Petruska M.L., and Huet B.A. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia. J Pediatr 126 (1995) 728-735
11. Uauy R., Zwiener R.J., Phillips M.J., Petruska M.L., and Bilheimer D.W. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis. J Pediatr 120 (1992) 892-898
12. Jaeger B.R., Tsobanelis T., Bengel F., Schwaiger M., and Seidel D. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. J Pediatr 141 (2002) 125-128